Laryngeal amyloidosis is a rare disease that was first documented in 1875. The incidence of the larynx limited amyloidosis is les than 1% of all benign lesions of larynx. It may occur as primary or secondary to other diseases. Generalized secondary am...
Laryngeal amyloidosis is a rare disease that was first documented in 1875. The incidence of the larynx limited amyloidosis is les than 1% of all benign lesions of larynx. It may occur as primary or secondary to other diseases. Generalized secondary amyloidosis is very rare among them. It is a condition characterized by the extracellular deposition of homogenous, eosinophilic, proteinous material in the form of fibrils. The aim of treatment is to maintatin or improve voice quality and to maintain laryngeal (amyloid light chain) type that was treated with KTP laser (potasium titany phosphate laser). (Korean J Otolaryngol 2003 ;46 :706-8)